Fig. 2.
Receiver Operating Characteristic (ROC) curve predictive of the therapeutic efficacy of PRP against Sub-clinical bubaline mastitis. The area under the curve (0.73) indicates the autologous PRP is an acceptable therapeutic.
Receiver Operating Characteristic (ROC) curve predictive of the therapeutic efficacy of PRP against Sub-clinical bubaline mastitis. The area under the curve (0.73) indicates the autologous PRP is an acceptable therapeutic.